Zepp Health (NYSE:ZEPP) Given a $13.87 Price Target by Fundamental Research Analysts

Zepp Health (NYSE:ZEPP) received a $13.87 price target from research analysts at Fundamental Research in a research note issued to investors on Tuesday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock. Fundamental Research’s price objective would indicate a potential upside of 473.61% from the company’s current price.

Zepp Health Stock Performance

Shares of ZEPP stock opened at $2.42 on Tuesday. The company has a market capitalization of $36.40 million, a price-to-earnings ratio of -0.97 and a beta of 0.71. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.87 and a current ratio of 1.21. Zepp Health has a one year low of $2.06 and a one year high of $4.38. The company’s 50-day moving average is $2.92 and its 200 day moving average is $3.05.

Institutional Trading of Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Virtu Financial LLC purchased a new stake in shares of Zepp Health Co. (NYSE:ZEPP) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 13,056 shares of the company’s stock, valued at approximately $57,000. Virtu Financial LLC owned approximately 0.09% of Zepp Health at the end of the most recent reporting period. Institutional investors own 52.61% of the company’s stock.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.